We are the world’s leading independent cancer charity dedicated to saving lives through research, influence and information.

Learn more about the science and the researchers Cancer Research UK supports. Search our discoveries by cancer type, cancer topic, and research near you.

Cancer Research UK is the world’s leading cancer charity dedicated to saving lives through research, influence and information. We support research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses. This pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives.

20 years of Cancer Research UK. 120 years of progress for people affected by cancer. Together we've come so far. But we have so much more to do. Our strategy sets out how we'll accelerate progress towards a world where everybody can lead longer, better lives, free from the fear of cancer. Read our strategy

Find out about possible causes of cancer, how cancer starts and grows, tests to diagnose it, and general information about treatments.

1 day ago · Radioactive scans for neuroendocrine tumours (NETs) Radioactive scans can help your doctors diagnose some types of neuroendocrine tumour (NET) . You have an injection of a low dose radioactive substance, which can show up on a scan. Radioactive scans include: octreotide scans (or Octreoscans) – these are also called somatostatin receptor scintigraphy …

We’re the world’s largest independent funder of cancer research, investing over $400 million each year across prevention, diagnosis and treatment. We do this because cancer is a global issue. The burden worldwide is on the rise, with 19.3 million new cases diagnosed in 2020 globally and 29.5 million new cases projected for 2040. We believe that by collaborating with global …

1 day ago · Types of neuroendocrine cancer Neuroendocrine cancers are a group of cancers that start in the neuroendocrine system . Doctors might also call them neuroendocrine neoplasms (NENs). But the terms mean the same thing. There are 2 key groups of neuroendocrine cancer: neuroendocrine tumours (NETs) neuroendocrine carcinomas (NECs) Neuroendocrine cancer …

Our clinical trials have improved treatments, helping more people survive cancer. From trials to test whether a treatment is safe and effective, to testing new combinations of treatments, our researchers are working hard to beat cancer.

Teclistamab is a type of targeted cancer drug. It is a treatment for myeloma. Find out about how you have it, possible side effects and other important information.